News release: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine

URL

https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid

Published Date

December 18, 2020

Organization

Food and Drug Administration (FDA)

Key Excerpts

“At this time, data are not available to determine how long the vaccine will provide protection, nor is there evidence that the vaccine prevents transmission of SARS-CoV-2 from person to person.”

Works of the United States government are not entitled to domestic copyright protection under U.S. law and are therefore in the public domain.

Medium

document

Topics

clinical trial endpoints,clinical trials,COVID-19,FDA approvals,manufacturers,vaccines